日本語 / English
The Sciences
iPS drug discovery
Hit-to-Lead Building Blocks
提携先企業：
- CONCEPT: Designed by top medicinal chemists from global pharma companies.
- UNIQUENESS: >95% of our compounds are unique (not overlap to major chemical finder site).
- STABILITY: All compounds are synthesisable (no virtual) with guaranteeing long-term storage.
- PRICING: Competitive pricing with optimising sales and production channels.
- FREQUENCY: More than 50 new compounds are monthly updated.
- LIBRARY: Available to supply unique and high-diverse library with combining the original building blocks.
In-Silico創薬
